SS2-10761-95197
3 vaccinations
11 coded responses
37 check-ins
11 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Registered in v-safe
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tiredness · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Brain fog, Feeling abnormal — Feeling: Fair · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — day 7, dose 1MedDRA: Muscle spasms — Feeling: GoodFree text: Leg crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-04-29
- 2021-05-08
- 2021-05-13
- 2021-05-20
- 2021-05-24
-
2021-05-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2021-07-08
Survey response — 3 months, dose 1MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Heavy menstrual bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-07
-
2021-10-25
Dose 2 — Moderna
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2022-01-24
- 2022-04-25
-
2022-06-22
Dose 3 — Moderna
-
2022-06-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-07-06
- 2022-07-13
-
2022-07-20
Survey response — day 28, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID 19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-27
Survey response — day 35, dose 3MedDRA: Malaise — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continued COVID symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-28
-
2022-08-03
Survey response — day 42, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID 19 ongoing symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Survey response — 3 months, dose 3MedDRA: Delivery, Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Childbirth and preeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-09-22
- 2022-09-22
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Moderna | No |
| 3 | 2022-06-22 | Moderna | No |
Call center
4 call center cases
2 successful · 2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Dizziness
Systemic reaction (other): Brain fog
Systemic reaction (other): Brain fog
Systemic reaction (other): Brain fog
Systemic reaction (other): Brain fog
Release 7 — day 7, dose 1
Systemic reaction (other): Leg cramps
Release 9 — 3 months, dose 1
Symptoms: Heavy menstrual bleeding
Release 12 — day 28, dose 3
Symptoms: COVID 19 infection
Release 12 — day 35, dose 3
Symptoms: Continued COVID symptoms
Release 12 — day 42, dose 3
Symptoms: COVID 19 ongoing symptoms
Release 12 — 3 months, dose 3
Symptoms: Childbirth and preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Brain fog | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release